Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1958 May;21(2):129–140. doi: 10.1136/jnnp.21.2.129

CLINICAL ASPECTS OF SUSCEPTIBILITY TO METHYLPENTYNOL

Edward Marley 1,2,*, Allen A Bartholomew 1,2
PMCID: PMC497306  PMID: 13539654

Full text

PDF
129

Images in this article

131Image
on p.131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLEULER M. Psychiatry of cerebral diseases. Br Med J. 1951 Nov 24;2(4742):1233–1238. doi: 10.1136/bmj.2.4742.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOCKNER S. A controlled clinical trial of methylpentynol (oblivon). J Ment Sci. 1957 Jan;103(430):218–221. doi: 10.1192/bjp.103.430.218. [DOI] [PubMed] [Google Scholar]
  3. BOURNE G. Methylpentynol in labour. Lancet. 1954 Sep 11;267(6837):522–525. doi: 10.1016/s0140-6736(54)90312-8. [DOI] [PubMed] [Google Scholar]
  4. CARES R. M., NEWMAN B., MAUCERI J. C. Poisoning by methyl-parafynol (dormison); fatal suicidal overdose of 3-methyl-pentyne-ol-3, a new hypnotic. Am J Clin Pathol. 1952 Feb;23(2):129–133. doi: 10.1093/ajcp/23.2.129. [DOI] [PubMed] [Google Scholar]
  5. CHAMBERS J. S., MARLEY E. Toxic effects and side-effects of methylpentynol. Br Med J. 1956 Dec 22;2(5007):1467–1470. [PMC free article] [PubMed] [Google Scholar]
  6. CHEVALLEY J., HEMINWAY N., MEYER G., FRANKHAUSER R., McGAVACK T. H. A clinical evaluation of methylparafynol as a soporific agent. N Y State J Med. 1952 Mar 1;52(5):572–574. [PubMed] [Google Scholar]
  7. CLEGHORN R. A. Drugs that produce deviations in mood, including anxiety, presumably without impairing capacities for orientation or at least secondarily to changes in mood. Am J Psychiatry. 1952 Feb;108(8):568–571. doi: 10.1176/ajp.108.8.568. [DOI] [PubMed] [Google Scholar]
  8. DELAMATER J. N. Acute exfoliative dermatitis due to dormison. Calif Med. 1952 Nov;77(5):339–340. [PMC free article] [PubMed] [Google Scholar]
  9. DICKEL H. A., DIXON H. H. Inherent dangers in use of tranquilizing drugs in anxiety states. J Am Med Assoc. 1957 Feb 9;163(6):422–426. doi: 10.1001/jama.1957.02970410012005. [DOI] [PubMed] [Google Scholar]
  10. Eggleton M. G. The diuretic action of alcohol in man. J Physiol. 1942 Aug 18;101(2):172–191. doi: 10.1113/jphysiol.1942.sp003973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GADDUM J. H. The effects of alcohol. Lect Sci Basis Med. 1954 1955;4:238–251. [PubMed] [Google Scholar]
  12. GLATT M. M. Spontaneous recovery from gross suicidal overdosage with methylpentynol (methyl-parafynol). J Nerv Ment Dis. 1955 Oct;122(4):390–392. doi: 10.1097/00005053-195510000-00012. [DOI] [PubMed] [Google Scholar]
  13. GUSTERSON F. R. The management of children undergoing tonsillectomy; premedication with methylpentynol. Lancet. 1955 May 7;268(6871):940–943. doi: 10.1016/s0140-6736(55)90965-x. [DOI] [PubMed] [Google Scholar]
  14. HIRSH H. L., ORSINGER W. H. Methylparafynol--a new type hypnotic. Preliminary report on its therapeutic efficacy and toxicity. Am Pract Dig Treat. 1952 Jan;3(1):23–26. [PubMed] [Google Scholar]
  15. HOLLANDER W. M. Dormison; a safe drug. J Iowa State Med Soc. 1954 Jun;44(6):257–257. [PubMed] [Google Scholar]
  16. HOWELLS D. E. Nystagmus as a physical sign in alcoholic intoxication. Br Med J. 1956 Jun 16;1(4980):1405–1406. doi: 10.1136/bmj.1.4980.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. ISBELL H., ALTSCHUL S., KORNETSKY C. H., EISENMAN A. J., FLANARY H. G., FRASER H. F. Chronic barbiturate intoxication; an experimental study. Arch Neurol Psychiatry. 1950 Jul;64(1):1–28. doi: 10.1001/archneurpsyc.1950.02310250007001. [DOI] [PubMed] [Google Scholar]
  18. ISBELL H. Addiction to barbiturates and the barbiturate abstinence syndrome. Ann Intern Med. 1950 Jul;33(1):108–121. doi: 10.7326/0003-4819-33-1-108. [DOI] [PubMed] [Google Scholar]
  19. KORNETSKY C. H. Psychological effects of chronic barbiturate intoxication. AMA Arch Neurol Psychiatry. 1951 May;65(5):557–567. doi: 10.1001/archneurpsyc.1951.02320050014002. [DOI] [PubMed] [Google Scholar]
  20. LEVIN M. Delirium: a gap in psychiatric teaching. Am J Psychiatry. 1951 Mar;107(9):689–694. doi: 10.1176/ajp.107.9.689. [DOI] [PubMed] [Google Scholar]
  21. LOVELACE R. E., ROITH A. I. Attempted suicide with methylpentynol and persomnia. Br Med J. 1955 May 21;1(4924):1258–1259. doi: 10.1136/bmj.1.4924.1258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MALONE H. J., KLIMKIEWICZ G. R., GRIBETZ H. J. A study of the hypnotic effect of dormison in children. J Pediatr. 1952 Aug;41(2):153–158. doi: 10.1016/s0022-3476(52)80050-2. [DOI] [PubMed] [Google Scholar]
  23. MARGOLIN S., PERLMAN P., VILLANI F., McGAVACK T. H. A new class of hypnotics; unsaturated carbinols. Science. 1951 Oct 12;114(2963):384–385. doi: 10.1126/science.114.2963.384. [DOI] [PubMed] [Google Scholar]
  24. MAY P. R. A., EBAUGH F. G. Dormison, a new type of hypnotic: its therapeutic use in psychiatric patients. Am J Psychiatry. 1953 Jun;109(12):881–888. doi: 10.1176/ajp.109.12.881. [DOI] [PubMed] [Google Scholar]
  25. PERLMAN P. L., SUTTER D., JOHNSON C. B. Further studies on the metabolic disposition of dormison (3-methyl-pentyne-ol-3) in dogs and man. J Am Pharm Assoc Am Pharm Assoc. 1953 Dec;42(12):750–752. doi: 10.1002/jps.3030421214. [DOI] [PubMed] [Google Scholar]
  26. SARGANT W. On chemical tranquillizers. Br Med J. 1956 Apr 28;1(4973):939–943. doi: 10.1136/bmj.1.4973.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SCHAFFARZICK R. W., BROWN B. J. The anticonvulsant activity and toxicity of methylparafynol (dormison) and some other alcohols. Science. 1952 Dec 12;116(3024):663–665. doi: 10.1126/science.116.3024.663. [DOI] [PubMed] [Google Scholar]
  28. SEARS W. G. Current therapeutics. XCIX. The non-barbiturate sedatives. Practitioner. 1956 Mar;176(1053):308–314. [PubMed] [Google Scholar]
  29. TUKEL K., TUKEL M. Dormison in electroencephalography. Electroencephalogr Clin Neurophysiol. 1952 Aug;4(3):363–366. doi: 10.1016/0013-4694(52)90065-5. [DOI] [PubMed] [Google Scholar]
  30. WIKLER A. Relationships between clinical effects of barbiturates and their neurophysiological mechanisms of action. Fed Proc. 1952 Jun;11(2):647–652. [PubMed] [Google Scholar]
  31. WILLIAMS R. L. Effects of dormison compared to seconal for sleep electroencephalograms. Electroencephalogr Clin Neurophysiol. 1954 Aug;6(3):497–498. doi: 10.1016/0013-4694(54)90066-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES